Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoVue-enhanced Ultrasound in Neoadjuvant Chemotherapy for Breast Cancer
NCT03385200Phase 3Unknown
- Sponsor
- RWTH Aachen University
- Start
- Dec 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sulfur hexafluoride in breast cancer, sponsored by RWTH Aachen University. Status: unknown.
02
Drugs
sulfur hexafluoride
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03385200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03385200.